CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-09 | Stueland Katherine Chief Executive Officer | Option exercise | +6,546 | 9,986 | ||
| 2025-09-09 | Stueland Katherine Chief Executive Officer | Sale | −3,639 | $128.05 | $466K | 6,347 |
| 2025-09-09 | Stueland Katherine Chief Executive Officer | Sale | −18 | $129.08 | $2K | 6,329 |
| 2025-09-09 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −6,546 | 32,733 | ||
| 2025-09-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +2,462 | 6,558 | ||
| 2025-09-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −1,266 | $128.05 | $162K | 5,292 |
| 2025-09-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −6 | $129.09 | $775 | 5,286 |
| 2025-09-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −2,462 | 12,311 | ||
| 2025-09-02 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −378 | $125.81 | $48K | 4,096 |
| 2025-09-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +717 | 4,474 | ||
| 2025-09-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −717 | 2,869 | ||
| 2025-08-27 | Ryan Jason Director | Sale | −8,818 | $125.07 | $1.1M | 132,538 |
| 2025-08-27 | Ryan Jason Director | Sale | −8,969 | $126.15 | $1.1M | 123,569 |
| 2025-08-27 | Ryan Jason Director | Sale | −5,443 | $127.44 | $694K | 118,126 |
| 2025-08-27 | Ryan Jason Director | Sale | −3,452 | $128.04 | $442K | 114,674 |
| 2025-08-27 | Ryan Jason Director | Sale | −9,890 | $129.59 | $1.3M | 104,784 |
| 2025-08-27 | Ryan Jason Director | Sale | −1,500 | $130.01 | $195K | 103,284 |
| 2025-08-27 | Ryan Jason Director | Sale | −1,150 | $129.65 | $149K | 11,904 |
| 2025-08-22 | Casdin Capital, LLC Director | Sale | −500,000 | $120.90 | $60.5M | 3,007,164 |
| 2025-07-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +753 | 4,145 |
Page 14 of 23 · 450 trades